脂肪质量指数和无脂肪质量指数对COPD患者的影响差异
Takashi Shimada1, Shotaro Chubachi1, Shiro Otake1
1Division of Pulmonary Medicine, Department of Medicine, Keio University School of Medicine, Tokyo, Japan.
Respiratory medicine
|June 30, 2023
概括
在慢性阻塞性肺病 (COPD) 患者中,低脂肪质量指数 (FMI) 和低无脂肪质量指数 (FFMI) 都会使肺气恶化. 然而,只有低的FFMI与较差的健康相关生活质量有关.
科学领域:
- 肺部病理学 肺部病理学
- 身体组成分析 身体成分分析
- 临床研究 临床研究
背景情况:
- 在慢性阻塞性肺病 (COPD) 患者中,脂肪质量指数 (FMI) 和无脂肪质量指数 (FFMI) 的独特临床影响尚未完全理解.
- 这项研究调查了FMI和FFMI对肺气,肺功能和COPD健康相关生活质量的不同影响.
研究的目的:
- 为了确定FMI和FFMI是否对COPD患者有不同的临床影响.
- 评估FMI和FFMI与肺重度,肺功能和生活质量之间的关联.
主要方法:
- 一项多中心前性队列研究,对228名COPD患者进行了3年的研究.
- 根据基线FMI和FFMI的中位数,患者被分为四组.
- 分析了肺 (LAA%),肺功能和圣乔治呼吸道问卷 (SGRQ) 的得分.
主要成果:
- 在四组中观察到肺气,肺功能和SGRQ得分的显著差异.
- 低FMI和低FFMI的群体患肺气的比例最高,肺功能最低,生活质量最差.
- 低FMI与更高的肺气和降低的肺功能相关 (IC/TLC,KCO);低FFMI与这些以及更差的SGRQ分数相关.
结论:
- FMI和FFMI对COPD的临床表现产生不同的影响.
- 低脂肪量和低肌肉量都会导致严重的肺气.
- 只有低肌肉质量 (FFMI) 与COPD患者的健康相关生活质量下降有关.
相关概念视频
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.5K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.5K
01:26COPD: Management Using Bronchodilators and Corticosteroids
250
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
250
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
2.8K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.9K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.9K
01:29Chronic Obstructive Pulmonary Disease-V: Management
2.6K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.6K
01:22Chronic Obstructive Pulmonary Disease
1.3K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.3K